Long-Acting Insulins Approved by FDA

PLAINSBORO, NJ – Physicians treating diabetes patients have new weapons in their arsenal.The Food and Drug Administration recently approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to improve glucose control in...

FDA Approves Option for Schizophrenia, Bipolar Treatment

JERSEY CITY, NJ – A new option for treating schizophrenia and bipolar disorder in adults has been approved by the Food and Drug Administration.The drug Vraylar, cariprazine in capsule form, is manufactured by Forest Laboratories LLC of Jersey City, NJ, and distributed...

U.S. Medicine Archives

U.S. Medicine Supplements

CE Credits